Emergent BioSolutions Inc - Company Profile

Powered by

All the sales intelligence you need on Emergent BioSolutions Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Emergent BioSolutions Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Emergent BioSolutions Inc.

Back to companies

Emergent BioSolutions Inc: Segment Analysis

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Business Description

Emergent BioSolutions Inc (Emergent) is a life sciences company that primarily focuses on providing innovative preparedness and response solutions to address accidental, deliberate, and naturally occurring Public Health Threats (PHTs).

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

Emergent is focused on achieving a balance in the products developed through a pipeline of innovative vaccines and therapeutics targeting diseases worldwide. The company is committed to continuous innovation to protect and enhance life. The R&D initiatives include developing and supporting plans to manufacture new products, with a talented team leading the way in Research & Development. The R&D unit of Emergent is the research & development team. This unit is responsible for leading the company's efforts in developing and supporting the plan to manufacture new products. The company has a pipeline of five products: Zaire ebolavirus, Smallpox, Mpox, Anthrax, and Pandemic Flu Vaccine. In FY2025, the company spent US$53.2 million on its R&D activities, which as a percentage of revenue stood at 7.1% and declined 24.7% YoY.

Business Segments

Overview

Focuses on the sales of NARCAN (naloxone HCl) Nasal Spray in the US and international markets. This product is sold over-the-counter at retail pharmacies, digital commerce websites, and through physician-directed prescriptions at various health and law enforcement agencies. The segment's strategy is to sell NARCAN Nasal Spray commercially and provide transition services to Bavarian.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

Focuses on the procurement of Medical Countermeasures (MCM) products and procured product candidates. It serves domestic and international government customers, with a focus on the US government, which is its largest customer. It also caters to domestic and international non-government organizations and governments outside of the US. Aims to procure MCM products and provide candidates primarily for government customers.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

Focuses on Bioservices, which are divided into three interrelated service pillars: development services, drug substance manufacturing, and drug product manufacturing. These services support all phases of the drug development life cycle. The customer base for Bioservices is primarily innovators in the biotechnology and pharmaceutical segments. Aims to provide a molecule-to-market offering, supporting all phases of the drug development life cycle.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Subscribe for access to business segment analysis Subscribe for access to business segment analysis Learn more



Geographical Segments

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Gain a 360-degree view of Emergent BioSolutions Inc and make more informed decisions for your business Gain a 360-degree view of Emergent BioSolutions Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer